Rationale for probiotic and antibiotic treatment strategies in inflammatory bowel diseases.
about
Central role of the gut epithelial barrier in the pathogenesis of chronic intestinal inflammation: lessons learned from animal models and human geneticsLactobacillus GG in inducing and maintaining remission of Crohn's diseaseProbiotics and the management of inflammatory bowel disease.Defensin deficiency, intestinal microbes, and the clinical phenotypes of Crohn's disease.Therapeutic approaches targeting intestinal microflora in inflammatory bowel disease.Probiotics in primary care pediatrics.Probiotics: do they help to control intestinal inflammation?Inflammatory bowel disease: Pandora's box, present and future.A review of complementary and alternative approaches to immunomodulation.Integrative medicine in gastrointestinal disease: evaluating the evidence.Rationale for probiotic treatment strategies in inflammatory bowel disease.The new prophylactic strategy for colon cancer in inflammatory bowel disease by modulating microbiota.Escherichia coli strain Nissle 1917 ameliorates experimental colitis via toll-like receptor 2- and toll-like receptor 4-dependent pathways.Preventive effects of Escherichia coli strain Nissle 1917 on acute and chronic intestinal inflammation in two different murine models of colitis.Probiotic Therapies for IBD.A molecular revolution in the study of intestinal microflora.
P2860
Q21131205-3F172021-A700-426F-9499-170D0914167EQ24806098-7EA65A03-1C57-4BC0-A437-67EE6A458A1CQ35854517-BA72987E-F47F-4555-B2BE-8E0F1569397EQ35993236-9254CAB8-A9B6-41EB-864D-C3AA7E68EA38Q36549836-C48757EB-4109-48B9-9BA6-AEED6CB6705FQ36557591-1077BFDD-1615-402F-8BB1-CC6636DA06ECQ36631503-618E659F-D680-4355-A93A-67E359A693D1Q36631518-C867571F-D968-420D-8355-BDD081B8F7B3Q37060108-E4F21070-0DD6-48F2-9DBB-8253EB8E1C30Q37345889-AC4D0AA9-A3A8-4767-9F24-45748DAFD4A0Q37345932-15C3B2D0-49C5-427A-900F-2AC87F2A9472Q38068230-EA01A6D0-CD7B-4D50-A39F-6DE079F2688BQ40264330-830D678D-1992-42EC-90A5-33286BD1604BQ40685749-21A92858-3619-46CE-BC3F-D1FE295F91BFQ41778200-C1D728E3-CA82-4C18-9336-CBF26D69A49FQ42844029-13ADAD81-D5DF-47FB-8CCF-E6CD7D7FBB49
P2860
Rationale for probiotic and antibiotic treatment strategies in inflammatory bowel diseases.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Rationale for probiotic and an ...... n inflammatory bowel diseases.
@ast
Rationale for probiotic and an ...... n inflammatory bowel diseases.
@en
type
label
Rationale for probiotic and an ...... n inflammatory bowel diseases.
@ast
Rationale for probiotic and an ...... n inflammatory bowel diseases.
@en
prefLabel
Rationale for probiotic and an ...... n inflammatory bowel diseases.
@ast
Rationale for probiotic and an ...... n inflammatory bowel diseases.
@en
P356
P1433
P1476
Rationale for probiotic and an ...... n inflammatory bowel diseases.
@en
P2093
Heiko C Rath
Michael Schultz
P304
P356
10.1159/000073243
P577
2003-01-01T00:00:00Z